Synapse - Jorg Cammenga

Jorg Cammenga

Research Focus

Former Employee. Molecular Pharmacology Program; Research Fellow

Recent additions – View all

Extracellular KIT receptor mutants, commonly found in core binding factor AML, are constitutively active and respond to imatinib mesylate
Journal Article

Cammenga, J.; Horn, S.; Bergholz, U.; Sommer, G.; Besmer, P.; Fiedler, W.; Stocking, C.
Blood (2005)

Fulltext@MSK | Save
AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34+ cells, allowing nerve growth factor-induced expansion
Journal Article

Mulloy, J. C.; Jankovic, V.; Wunderlich, M.; Delwel, R.; Cammenga, J.; Krejci, O.; Zhao, H.; Valk, P. J. M.; Löwenberg, B.; Nimer, S. D.
Proceedings of the National Academy of Sciences of the United States of America (2005)

Fulltext@MSK | Save
Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element
Journal Article

Mulloy, J. C.; Cammenga, J.; Berguido, F. J.; Wu, K.; Zhou, P.; Comenzo, R. L.; Jhanwar, S.; Moore, M. A. S.; Nimer, S. D.
Blood (2003)

Fulltext@MSK | Save

Co-authors at MSK

15

Nimer
9

Mulloy
7

Berguido
5

Moore
3

Mackenzie
2

Alvarez
2

Comenzo
2

Klampfer
2

Viale
2

Wu
2

Zhou
1

Besmer
1

Boccuni
1

Hedvat
1

Jackson
1

Jakubowiak
1

Jankovic
1

Jhanwar
1

Macgrogan
1

Scandura
1

Sokolic
1

Sommer
1

Zhao

Types of Work

Publications

Blood (10)
Current Oncology Reports (1)
Experimental Hematology (1)
Leukemia Research (1)
Oncogene (1)
Pflügers Archiv - European Journal of Physiology (1)
Proceedings of the National Academy of Sciences of the United States of America (1)